Resultados de la búsqueda

Kresoja KP, Rubini Giménez M, Thiele H. The SEX-SHOCK score - The Emperor's New Clothes? Eur Heart J (2024) 45:4579-4581

Garcia-Pavia P, Oreziak A, Masri A, Barriales-Villa R, Abraham TP, Owens AT, Jensen MK, Wojakowski W, Seidler T, Hagege A, Lakdawala NK, Wang A, Wheeler MT, Choudhury L, Balaratnam G, Shah A, Fox S, Hegde SM, Olivotto I. Long-term effect of mavacamten in obstructive hypertrophic cardiomyopathy. Eur Heart J (2024) 45:5071-5083.

Pascual-Figal D, Núñez J, Pérez-Martínez MT, González-Juanatey JR, Taibo-Urquia M, Llàcer Iborra P, Delgado J, Villar S, Mirabet S, Aimo A, Riquelme-Pérez A, Anguita Sánchez M, Martínez-Sellés M, Noguera-Velasco JA, Ibáñez B, Bayés-Genís A; COLICA investigators. Colchicine in acutely decompensated heart failure: the COLICA trial. Eur Heart J (2024) 45:4826-4836
Link to the full text in Repisalud

Verdonschot JAJ, Fuster JJ, Walsh K, Heymans SRB. The emerging role of clonal haematopoiesis in the pathogenesis of dilated cardiomyopathy. Eur Heart J (2024) 45:4797-4807
Link to the full text in Repisalud

Amier RP, Beijnink CWH, Palomares JR, Smulders MW, Sanchez GP, Valente F, Van Rossum AC, Van Royen N, Ibanez B, Nijveldt R. Long-term prognostic value of microvascular obstruction by cardiac magnetic resonance in ST-segment elevation myocardial infarction. Eur Heart J (2024) 45

El-Am E, Abbasi M, Rahme S, Al Abcha T, Cheng R, Ustunkaya T, Ellis C, Cariou E, Ullah I, Ambardekar A, Vasbinder A, Hayek S, Garcia-Pavia P, Ruberg F, Grogan M. Cardiac amyloidosis and left atrial appendage closure: a multicenter retrospective study. Eur Heart J (2024) 45

Garcia C Perez, Gomez-Ramirez D, Perez-Serrano J, Garcia-Arribas D, Jeronimo A, Saez C, Ferrera C, Vilacosta I, Olmos C. The 5-Item Modified Frailty Index (mFI-5) for risk stratification of patients with infective endocarditis undergoing cardiac surgery. Eur Heart J (2024) 45

Garcia-Pavia P, Oreziak A, Masri A, Barriales-Villa R, Abraham TP, Owens AT, Jensen M, Wojakowski W, Seidler T, Hagege A, Balaratnam G, Shah A, Fox S, Hegde SM, Olivotto I. Long-term safety and efficacy of mavacamten in obstructive hypertrophic cardiomyopathy: up to 3.5-year follow-up results of the EXPLORER cohort of MAVA-Long-Term Extension study. Eur Heart J (2024) 45

González Juanatey JR, Castellano Vazquez JM, Ponte-Negretti CI, Abreu A, Araujo F, Parkhomenko A, Gomez Alvarez E, Weisser B, Sosa-Liprandi A, Pineiro DJ, Fuster V. The cardiovascular polypill strategy (acetyl salicylic acid, atorvastatin, ramipril) as baseline treatment after a cardiovascular event supported by compelling evidence: a global expert consensus. Eur Heart J (2024) 45

Garcia Lunar I, Dantas AP, Ascaso M, Pruna R, Galan-Arriola C, Sandoval E, Solanes N, Rigol M, Ibanez B, Pereda D, Garcia-Alvarez A. CILP1 and NTproBNP in pulmonary hypertension and right ventricular pressure overload: a translational experimental study. Eur Heart J (2024) 45